Boston Scientific Corp. Stock Underperforms Wednesday When Compared To Competitors Despite Daily Gains

Dow Jones11-28 05:40

DJ Boston Scientific Corp. Stock Underperforms Wednesday When Compared To Competitors Despite Daily Gains

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Boston Scientific Corp. $(BSX)$ inched 0.60% higher to $90.75 Wednesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index falling 0.38% to 5,998.74 and Dow Jones Industrial Average falling 0.31% to 44,722.06.

This was the stock's second consecutive day of gains.

Boston Scientific Corp. closed $1.18 below its 52-week high ($91.93), which the company reached on November 22nd.

The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as Abbott Laboratories $(ABT)$ rose 0.84% to $118.95, Medtronic PLC $(MDT)$ rose 0.69% to $86.27, and Stryker Corp. $(SYK)$ fell 0.40% to $388.14.

Data source: Dow Jones Market Data, FactSet. Data compiled November 27, 2024.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

 

(END) Dow Jones Newswires

November 27, 2024 16:40 ET (21:40 GMT)

Copyright (c) 2024 Dow Jones & Company, Inc.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment